Aortic regurgitation · people with confirmed diagnosis of Marfan syndrome
Beta‐blockers showed no clear difference in aortic regurgitation compared with placebo, no treatment or surveillance only (low certainty).
1 finding from 1 review
Congestive heart failure · people with confirmed diagnosis of Marfan syndrome
Beta‐blockers showed no clear difference in congestive heart failure compared with placebo, no treatment or surveillance only (low certainty).
1 finding from 1 review
Cardiovascular surgery · people with confirmed diagnosis of Marfan syndrome
Beta‐blockers showed no clear difference in cardiovascular surgery compared with placebo, no treatment or surveillance only (low certainty).
1 finding from 1 review
Aortic root diameter > 6 cm · people with confirmed diagnosis of Marfan syndrome
Beta‐blockers showed no clear difference in aortic root diameter > 6 cm compared with placebo, no treatment or surveillance only (low certainty).
1 finding from 1 review
Limb salvage · people who underwent a lower limb revascularisation
Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in limb salvage rate compared with pulse palpation plus arterial pressure index (ABI or TBI) (short term) (low certainty).
1 finding from 1 review
All‐cause mortality · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Functional walking ability · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical severity scales · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life scores · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary patency (24 months) · people who underwent a lower limb revascularisation
Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in vessel or graft secondary patency compared with pulse palpation plus arterial pressure index (ABI or TBI) (short term) (low certainty).
1 finding from 1 review
All‐cause mortality · people who underwent a lower limb revascularisation
Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in all‐cause mortality compared with pulse palpation plus arterial pressure index (ABI or TBI) (short term) (low certainty).
1 finding from 1 review
Functional walking ability · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical severity scales · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life scores · people who underwent a lower limb revascularisation
1 finding from 1 review
Limb salvage · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary patency (24 months) · people who underwent a lower limb revascularisation
Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in vessel or graft secondary patency compared with pulse palpation plus arterial pressure index (ABI or TBI) (long term) (low certainty).
1 finding from 1 review
Intervention not reported
Occurrence of CIN2+ in histology at 18 months · women with ASCUS or LSIL
The intervention probably leads to higher occurrence of CIN2+ in histology at 18 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Occurrence of CIN2+ in histology at 24 months · women with ASCUS or LSIL
The intervention showed no clear difference in occurrence of CIN2+ in histology at 24 months (low certainty).
1 finding from 1 review
Intervention not reported
Occurrence of CIN3+ in histology at 18 months · women with ASCUS or LSIL
The intervention showed no clear difference in occurrence of CIN3+ in histology at 18 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Occurrence of CIN3+ in histology at 24 months · women with ASCUS or LSIL
The intervention showed no clear difference in occurrence of CIN3+ in histology at 24 months (low certainty).
1 finding from 1 review